About WuXi PharmaTech (Cayman) (NYSE:WX)
WuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.
Industry, Sector and Symbol
Industry Biotechnology & Medical Research - NEC
SectorBiotechnology & Medical Research - NEC
Trailing P/E Ratio38.9067796610169
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity6.93%
Return on Assets4.67%
WuXi PharmaTech (Cayman) (NYSE:WX) Frequently Asked Questions
What is WuXi PharmaTech (Cayman)'s stock symbol?
WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."
How were WuXi PharmaTech (Cayman)'s earnings last quarter?
WuXi PharmaTech (Cayman) Inc. (NYSE:WX) issued its quarterly earnings results on Tuesday, November, 3rd. The medical research company reported $0.31 EPS for the quarter, meeting analysts' consensus estimates of $0.31. The medical research company had revenue of $213.60 million for the quarter, compared to analysts' expectations of $205.24 million. WuXi PharmaTech (Cayman) had a net margin of 7.52% and a return on equity of 6.93%. The business's quarterly revenue was up 23.0% on a year-over-year basis. During the same period last year, the business earned $0.54 earnings per share. View WuXi PharmaTech (Cayman)'s Earnings History.
Who are some of WuXi PharmaTech (Cayman)'s key competitors?
Some companies that are related to WuXi PharmaTech (Cayman) include Covance (CVD), Horizon Discovery Group (HZD), Cellular Dynamics International (ICEL), Galectin Therapeutics (GALT), Regulus Therapeutics (RGLS), Silence Therapeutics (SLN), Bioventix (BVXP), ReNeuron Group (RENE), Vernalis (VER), Synairgen (SNG), OpGen (OPGN), Akers Biosciences (AKR) and InterMune (ITMN).
How do I buy WuXi PharmaTech (Cayman) stock?
Shares of WuXi PharmaTech (Cayman) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WuXi PharmaTech (Cayman)'s stock price today?
One share of WuXi PharmaTech (Cayman) stock can currently be purchased for approximately $45.91.
How big of a company is WuXi PharmaTech (Cayman)?
WuXi PharmaTech (Cayman) has a market capitalization of $3.27 billion.
How can I contact WuXi PharmaTech (Cayman)?
WuXi PharmaTech (Cayman)'s mailing address is 288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone, SHANGHAI, SHA 200131, China. The medical research company can be reached via phone at +86-21-50461111.
MarketBeat Community Rating for WuXi PharmaTech (Cayman) (WX)MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
WuXi PharmaTech (Cayman) (NYSE:WX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
WuXi PharmaTech (Cayman) (NYSE:WX) Earnings History and Estimates Chart
WuXi PharmaTech (Cayman) (NYSE WX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/3/2015||Q3||$0.31||$0.31||$205.24 million||$213.60 million||View||N/A|
|8/13/2015||Q215||$0.39||$0.38||$195.26 million||$194.14 million||View||Listen|
|5/13/2015||Q1||$0.32||$0.36||$174.29 million||$180.00 million||View||Listen|
|3/5/2015||Q414||$0.53||$0.55||$189.54 million||$190.60 million||View||Listen|
|11/12/2014||Q314||$0.48||$0.54||$172.60 million||$173.60 million||View||Listen|
|8/13/2014||Q214||$0.47||$0.49||$162.11 million||$163.40 million||View||Listen|
|5/14/2014||Q114||$0.39||$0.30||$145.00 million||$146.70 million||View||Listen|
|3/5/2014||Q413||$0.43||$0.53||$155.76 million||$157.10 million||View||N/A|
|11/13/2013||Q313||$0.39||$0.47||$145.29 million||$146.70 million||View||Listen|
|8/12/2013||Q2 2013||$0.39||$0.46||$141.10 million||$142.33 million||View||N/A|
|5/13/2013||Q1 2013||$0.32||$0.35||$130.02 million||$131.90 million||View||Listen|
|3/7/2013||Q4 2012||$0.30||$0.38||$123.71 million||$125.70 million||View||Listen|
|11/12/2012||Q312||$0.30||$0.36||$123.17 million||$125.84 million||View||N/A|
WuXi PharmaTech (Cayman) (NYSE:WX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for WuXi PharmaTech (Cayman) (NYSE:WX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for WuXi PharmaTech (Cayman) (NYSE WX)
No insider trades for this company have been tracked by MarketBeat.com
WuXi PharmaTech (Cayman) (NYSE WX) News Headlines
WuXi PharmaTech (Cayman) (NYSE:WX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
WuXi PharmaTech (Cayman) (NYSE:WX) Income Statement, Balance Sheet and Cash Flow Statement
WuXi PharmaTech (Cayman) (NYSE WX) Stock Chart for Thursday, January, 18, 2018